Novavax
NVAX
#5617
Rank
ยฃ0.96 B
Marketcap
ยฃ5.88
Share price
-0.81%
Change (1 day)
24.52%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): ยฃ0.35 Billion

According to Novavax's latest financial reports the company's current earnings are ยฃ1.08 Billion. , an increase over its 2024 earnings that were of -ยฃ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 ยฃ0.34 B-396.87%
2024 -ยฃ0.12 Billion-70.39%
2023 -ยฃ0.39 Billion-16.59%
2022 -ยฃ0.47 Billion-62.58%
2021 -ยฃ1.25 Billion320.54%
2020 -ยฃ0.3 Billion234.22%
2019 -ยฃ88.9 Million-30.17%
2018 -ยฃ0.13 Billion1.69%
2017 -ยฃ0.13 Billion-36.44%
2016 -ยฃ0.2 Billion70.4%
2015 -ยฃ0.12 Billion89.27%
2014 -ยฃ61.08 Million59.83%
2013 -ยฃ38.22 Million81.9%
2012 -ยฃ21.01 Million50.33%
2011 -ยฃ13.98 Million
2009 -ยฃ27.58 Million8.8%
2008 -ยฃ25.35 Million18.01%
2007 -ยฃ21.48 Million18.33%
2006 -ยฃ18.16 Million168.31%
2005 -ยฃ6.77 Million-62.51%
2004 -ยฃ18.05 Million52.4%
2003 -ยฃ11.85 Million-28.21%
2002 -ยฃ16.5 Million
2000 -ยฃ9.4 Million177%
1999 -ยฃ3.4 Million-11.54%
1998 -ยฃ3.84 Million10.64%
1997 -ยฃ3.47 Million-9.62%
1996 -ยฃ3.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
ยฃ12.06 B 3,418.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ7.51 B 2,093.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.40 B 2,935.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ7.29 B 2,029.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-ยฃ0.52 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ15.24 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-ยฃ6 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.19 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA